-
May 27, 2025Prisys Biotech's NHP Atopic Dermatitis Model For Anti-Pruritic Drug DevelopmentDiscover how Prisys Biotech's Non-Human Primate (NHP) Atopic Dermatitis (AD) model accurately simulates human itch, aiding in the preclinical evaluation of novel anti-pruritic t... -
May 20, 2025Atopic Dermatitis: How Cynomolgus Monkey Models Advance Precision TherapeuticsExplore Prisys Biotech’s cynomolgus monkey model for atopic dermatitis (AD), which closely mimics human disease through OVA-induced sensitization, enabling advanced preclinical ... -
May 12, 2025Asthma Research: Why Non-Human Primate Models Are Pivotal For Novel Drug Deve...Discover why Non-Human Primate (NHP) models, especially cynomolgus monkeys, are crucial for asthma drug development. Prisys Biotech offers advanced NHP asthma models with compre... -
May 08, 2025Understanding Antisense Oligonucleotide (ASO) Pharmacokinetics: Key Factors i...Explore the complex pharmacokinetics of antisense oligonucleotide (ASO) drugs, including absorption and distribution influenced by physicochemical properties, administration rou...
-
Apr 30, 2025NHP Inhalation Studies For Biologics: PRISYS's Specialized Preclinical CRO Se...Develop inhaled biologics faster with PRISYS BIOTECH. We offer comprehensive NHP preclinical inhalation studies, leveraging advanced technology & expertise. -
Apr 29, 2025Advanced Preclinical Inhalation Studies: Technical Capabilities And Expertise...Explore the technical requirements for preclinical inhalation drug studies. Learn about aerosol monitoring, particle sizing, specialized delivery systems (oro-nasal, IT, IN), an...
-
Apr 25, 2025Understanding Pharmacokinetics (PK): Key Parameters And Applications in Drug ...Explore the fundamentals of Pharmacokinetics (PK) and its critical role in drug development. Understand key PK parameters (AUC, Cmax, t1/2, CL) and their application in dose sel... -
Apr 22, 2025Intracerebroventricular (ICV) Injection: Precision CNS Delivery For Preclinic...Explore Intracerebroventricular (ICV) injection for direct CNS drug delivery. Learn about preclinical procedures, species considerations, repeat dosing techniques like the Ommay... -
Apr 18, 2025Intracerebral (ICM) Injection: Precision Targeting For CNS Therapeutics – Pre...Explore intracerebral (ICM) injection for targeted CNS drug delivery. Understand non-clinical procedures, advantages, risks, and safety considerations for developing brain thera... -
Apr 16, 2025Intrathecal (IT) Injection: A Direct CNS Delivery Route For Advanced Therapie...Explore the advantages, challenges, and critical non-clinical considerations of intrathecal (IT) injection for CNS drug delivery. Learn about preclinical models, procedures, and...
-
Apr 11, 2025Advancing Parkinson's Disease Research With The NHP ModelPrisys Biotech offers a validated MPTP-induced Non-Human Primate (NHP) model of Parkinson's Disease (PD), featuring comprehensive behavioral, neuroimaging, and pathological asse...
-
Apr 08, 2025Preclinical PK/PD Studies & NHP Models For Drug Development | Prisys BiotechPrisys Biotech delivers expert preclinical Pharmacokinetics (PK) & Pharmacodynamics (PD) services, specializing in NHP models. Accelerate your drug development and IND submissio...
